08.01.2013 • News

Innospec Aims for Sub-$300 Million Acquisition by March End

Fuel additives maker Innospec is looking to buy an oilfield specialty company for less than $300 million by the end of the first quarter, its top executive said.

"We are combing all regions to look at small companies that are under $300 million, some public but mostly privately owned," Chief Executive Patrick Williams told Reuters in an interview.

Innospec withdrew its $745 million offer for TPC Group in early December, paving the way for the acquisition of the chemicals maker by private equity firms First Reserve Corp and SK Capital Partners.

Innospec shares have risen about 13% since it dropped the bid that was backed by Blackstone Group.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.